FIELD: medicine, pharmaceutics.
SUBSTANCE: method of obtaining erythromycin tablets consists in the following: mixture of erythromycin and polyvinylpyrrolidone with molecular weight 10000±2000 with their weight ratio 1:0.125-2 is dissolved in ethanol. Ratio of alcohol and erythromycin and polyvinylpyrrolidone mixture constitutes 1:3-7. After that solution is introduced into device for granulate drying, solvent is removed at temperature 37-41°C. To obtained mass with weight ratio of components 1:2-4 added is mixture of microcrystalline cellulose, starch, lactose, taken with weight ratio 1:2.5-3:6.5-7, respectively. Magnesium stearate is introduced into mixture in amount 2-3% of granulate weight and mixture is tabletted.
EFFECT: claimed method of obtaining erythromycin tablets allows to increase its bioavailability and antibacterial activity.
1 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING RUTIN TABLETS | 2013 |
|
RU2523562C1 |
METHOD FOR PRODUCING INSTANT FORMULATION OF FURACILIN (OPTIONAL) | 2014 |
|
RU2578456C1 |
METHOD OF PRODUCING DICLOFENAC CAPSULES | 2015 |
|
RU2602681C1 |
INSTANTLY SOLUBLE DOSAGE FORM OF METRONIDAZOLE AND METHOD OF ITS OBTAINING (VERSIONS) | 2021 |
|
RU2797947C2 |
RAPIDLY DISSOLVING DOSAGE FORM OF FURAZOLIDONE AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2772430C1 |
RAPIDLY DISSOLVING PHARMACEUTICAL FORM OF INDOMETHACIN AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2020 |
|
RU2764032C1 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
METHOD FOR PRODUCING COMPOSITION AND COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 2001 |
|
RU2182825C1 |
AFOBASOL-BASE PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2289403C2 |
PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL EFFECT AND METHOD OF ITS PREPARING | 2001 |
|
RU2190403C1 |
Authors
Dates
2010-11-10—Published
2009-06-04—Filed